(Q38067485)

28 August 2017

1 reference

title

When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist? (English)

1 reference

28 August 2017

1

1 reference

28 August 2017

3

Franz H Messerli

1 reference

28 August 2017

Sunil Kumar

2

1 reference

28 August 2017

12 December 2012

1 reference

28 August 2017

Congestive Heart Failure

1 reference

28 August 2017

19

1 reference

28 August 2017

3

1 reference

28 August 2017

107-115

1 reference

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

28 August 2017

1 reference

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

21 January 2018

1 reference

Aldosterone blockade in patients with systolic left ventricular dysfunction

21 January 2018

1 reference

Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction

21 January 2018

1 reference

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

21 January 2018

1 reference

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

21 January 2018

1 reference

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure

21 January 2018

1 reference

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

21 January 2018

1 reference

Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results

21 January 2018

1 reference

Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial

21 January 2018

1 reference

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure

21 January 2018

1 reference

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

Spironolactone Reduced Arrhythmia and Maintained Magnesium Homeostasis in Patients With Congestive Heart Failure

21 January 2018

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

21 January 2018

1 reference

Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction

21 January 2018

1 reference

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

Left ventricular remodeling after acute myocardial infarction: does eplerenone have an effect?

21 January 2018

1 reference

Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure

21 January 2018

1 reference

Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CHF.12011

1 reference

28 August 2017

1 reference

PubMed ID

23241032